Literature DB >> 21825134

Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85alpha Src homology-2 domains.

Jennifer Y Lee1, Yu-Hsin Chiu, John Asara, Lewis C Cantley.   

Abstract

Class IA PI3Ks are activated by growth factor receptors and generate lipid second messengers that mediate downstream responses including cell growth, cell migration, and cell survival. The p85 regulatory subunit of PI3K contains Src homology-2 (SH2) domains that mediate binding to tyrosine-phosphorylated receptors or adaptor proteins to facilitate localization and activation of PI3K at the plasma membrane. We report here that persistent activation of PKC family members by phorbol ester stimulation in cells leads to phosphorylation of two serine residues at analogous sites on both SH2 domains of p85α (S361 and S652). The modified serine residues are located in the phospho-tyrosine binding pockets of the two SH2 domains, and in the crystal structures the phosphate moieties are predicted to occupy the same space as the phosphate moieties of bound phospho-tyrosine peptides. Consistent with this prediction, phosphorylation at these serine residues or mutation to aspartate inhibits binding of p85α to tyrosine-phosphorylated peptides. We provide evidence that protein kinase D, which is phosphorylated and activated by PKCs, mediates phosphorylation of S652 in the C-terminal SH2 domain. These results reveal cross talk between PKC signaling and PI3K signaling that impairs PI3K pathway activation under conditions of persistent PKC (and protein kinase D) activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825134      PMCID: PMC3161555          DOI: 10.1073/pnas.1107747108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling.

Authors:  Bernard A Liu; Karl Jablonowski; Monica Raina; Michael Arcé; Tony Pawson; Piers D Nash
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

Review 3.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.

Authors:  Jeffrey A Engelman; Ji Luo; Lewis C Cantley
Journal:  Nat Rev Genet       Date:  2006-08       Impact factor: 53.242

4.  Biochemistry. PI3K charges ahead.

Authors:  Jennifer Y Lee; Jeffrey A Engelman; Lewis C Cantley
Journal:  Science       Date:  2007-07-13       Impact factor: 47.728

5.  Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival.

Authors:  Kohjiro Ueki; David A Fruman; Saskia M Brachmann; Yu-Hua Tseng; Lewis C Cantley; C Ronald Kahn
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

6.  Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling.

Authors:  Kohjiro Ueki; David A Fruman; Claudine M Yballe; Mathias Fasshauer; Johannes Klein; Tomoichiro Asano; Lewis C Cantley; C Ronald Kahn
Journal:  J Biol Chem       Date:  2003-09-22       Impact factor: 5.157

7.  Insulin induces SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improvement in glucose metabolism.

Authors:  Li Li; Line M Grønning; Per O Anderson; Suling Li; Klaus Edvardsen; Jim Johnston; Dimitris Kioussis; Peter R Shepherd; Ping Wang
Journal:  J Biol Chem       Date:  2004-04-27       Impact factor: 5.157

8.  The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex.

Authors:  Ji Luo; Seth J Field; Jennifer Y Lee; Jeffrey A Engelman; Lewis C Cantley
Journal:  J Cell Biol       Date:  2005-07-25       Impact factor: 10.539

9.  Role of the PI3K regulatory subunit in the control of actin organization and cell migration.

Authors:  C Jiménez; R A Portela; M Mellado; J M Rodríguez-Frade; J Collard; A Serrano; C Martínez-A; J Avila; A C Carrera
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

10.  Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit.

Authors:  Nabil Miled; Ying Yan; Wai-Ching Hon; Olga Perisic; Marketa Zvelebil; Yuval Inbar; Dina Schneidman-Duhovny; Haim J Wolfson; Jonathan M Backer; Roger L Williams
Journal:  Science       Date:  2007-07-13       Impact factor: 47.728

View more
  32 in total

1.  Role of amplification in phospholipase Cγ2 activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori: effect of ghrelin.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2014-11-02       Impact factor: 4.473

2.  Protein kinase Cα gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.

Authors:  Julia A Callender; Yimin Yang; Gema Lordén; Natalie L Stephenson; Alexander C Jones; John Brognard; Alexandra C Newton
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

3.  Modulation of gastric mucosal inflammatory responses to Helicobacter pylori via ghrelin-induced protein kinase Cδ tyrosine phosphorylation.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2014-05-20       Impact factor: 4.473

4.  Dynamic modulation of innate immune response by varying dosages of lipopolysaccharide (LPS) in human monocytic cells.

Authors:  Matthew C Morris; Elizabeth A Gilliam; Julia Button; Liwu Li
Journal:  J Biol Chem       Date:  2014-06-26       Impact factor: 5.157

5.  Interaction between CD133 and PI3K-p85 promotes chemoresistance in gastric cancer cells.

Authors:  Shuzheng Song; Guoqing Pei; Yaqiong Du; Jugang Wu; Xiaochun Ni; Shoulian Wang; Bojian Jiang; Meng Luo; Jiwei Yu
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

6.  p84 forms a negative regulatory complex with p110γ to control PI3Kγ signalling during cell migration.

Authors:  Michelle E Turvey; Manuela Klingler-Hoffmann; Peter Hoffmann; Shaun R McColl
Journal:  Immunol Cell Biol       Date:  2015-03-10       Impact factor: 5.126

7.  BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity.

Authors:  Yu-Hsin Chiu; Jennifer Y Lee; Lewis C Cantley
Journal:  Mol Cell       Date:  2014-03-20       Impact factor: 17.970

Review 8.  Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling.

Authors:  Melany J Wagner; Melissa M Stacey; Bernard A Liu; Tony Pawson
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

9.  Regulation of Macrophage Apoptosis and Atherosclerosis by Lipid-Induced PKCδ Isoform Activation.

Authors:  Qian Li; Kyoungmin Park; Yu Xia; Motonobu Matsumoto; Weier Qi; Jialin Fu; Hisashi Yokomizo; Mogher Khamaisi; Xuanchun Wang; Christian Rask-Madsen; George L King
Journal:  Circ Res       Date:  2017-08-30       Impact factor: 17.367

10.  Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis.

Authors:  Daisuke Hoshino; Jerome Jourquin; Shane Weller Emmons; Tyne Miller; Margalit Goldgof; Kaitlin Costello; Darren R Tyson; Brandee Brown; Yiling Lu; Nagendra K Prasad; Bing Zhang; Gordon B Mills; Wendell G Yarbrough; Vito Quaranta; Motoharu Seiki; Alissa M Weaver
Journal:  Sci Signal       Date:  2012-09-11       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.